Cataract surgery has become routine, and patients have high expectations for their eyesight after the procedure. Indeed, many hope to become spectacle-free. Astigmatism is treatable in most cases but, whereas toric intraocular lenses are routine in cases of high astigmatism, lower cylinder astigmatism (0.75 D to 1.75 D) has not been so easy to correct. In these patients, careful planning of femtosecond laser arcuate keratotomy (FS-AK) is a great option to achieve the best possible visual outcome.
The Optimeyes™ software from Optimo Medical moves surgical planning from paper-based nomograms (predicated on statistical parameters, including patient age and degree of astigmatism) to innovative computer-based calculations – in line with a trend toward personalized and digitalized medicine. The software system, which was several years in the making, couples a deep understanding of corneal biomechanics with expertise in mathematics, ophthalmology, computer science, and software engineering to generate sophisticated algorithms that provide a unique and patient-specific solution.
“Thanks to our software, the gap between existing high-tech diagnostic and laser eye surgery devices can finally be bridged with a high-tech planning solution – tailored to the individual patient,” explains Harald P. Studer, CEO of Optimo Medical. “Our team has researched and developed extensive know-how on corneal biomechanics, and we are proud to call ourselves experts in eye surgery prediction on a global scale.”
A patient’s personal corneal tomographic measurements are imported into the software that creates a virtual copy of the anterior segment of this precise eye – a “digital twin.” Using this twin model, Optimeyes™ performs virtual dry runs of the operation “in silico” to find the precise surgical parameters that will optimize the visual acuity outcome and minimize risk for each unique individual.
In short, Optimeyes™ offers “Expert Simulations for Personalized Results” and allows the surgeon to get the very best possible results from the femtosecond laser. The impact of Optimeyes™ in the field has been recognized with several awards: the WA de Vigier award for young entrepreneurs in 2017, the Swiss Excellence Product Award in 2018, and the zkb Pioneer Prize in 2019. CE-certified since March 2018, Optimeyes™ is available in the European Union, where it is installed in multiple clinics.
The software is currently not for sale in the USA or any other region outside of Europe.
For more information, visit www.optimo-medical.com.
